Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00877279 · ClinicalTrials.gov registry record · Phase 3
Multicenter Study of the Safety and Efficacy of Dermal Filler, Belotero® Soft
A Phase 3 study, sponsored by Merz North America.
- Completed
- Registry status
- Phase 3
- Development phase
- 64
- Enrollment target
NCT00877279 is a Phase 3 study that has completed, run by Merz North America. The registered enrollment target is 64 participants.
The verdict
NCT00877279, a Phase 3 study, has completed, sponsored by Merz North America.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 64 participants
- Enrollment target
Study Summary
This study is to determine the safety and effectiveness of Belotero® Soft compared to active comparator in the correction of mild facial wrinkles, such as nasolabial folds.
Interventions
- DEVICE CosmoDerm1
- DEVICE Belotero Soft
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2007-11 |
| Est. Completion | 2008-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00877279
The ClinicalTrials.gov registry entry for NCT00877279 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Merz North America, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which CosmoDerm1 is the first listed.
NCT00877279 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00877279 about?
NCT00877279 is a clinical study titled "Multicenter Study of the Safety and Efficacy of Dermal Filler, Belotero® Soft". This study is to determine the safety and effectiveness of Belotero® Soft compared to active comparator in the correction of mild facial wrinkles, such as nasolabial folds.
What is the current status of trial NCT00877279?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 64 participants. The study started on 2007-11. Estimated completion is 2008-03.
What interventions are being tested in trial NCT00877279?
The interventions under investigation include: CosmoDerm1 (DEVICE), Belotero Soft (DEVICE).
Who is sponsoring clinical trial NCT00877279?
This trial is sponsored by Merz North America, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.